Aquestive Therapeutics, Inc. (AQST)

NASDAQ: AQST · Real-Time Price · USD

4.200

-0.090 (-2.10%)

Mar 10, 2026, 4:00 PM EDT - Market closed

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Pharmaceuticals	44.55M	57.56M	50.58M	47.68M	50.83M
Pharmaceuticals Growth	-22.61%	13.80%	6.09%	-6.20%	10.87%
Total	44.55M	57.56M	50.58M	47.68M	50.83M
Total Growth	-22.61%	13.80%	6.09%	-6.20%	10.87%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
United States	29.60M	39.93M	37.10M	40.79M	42.86M
United States Growth	-25.86%	7.62%	-9.04%	-4.83%	4.65%
Ex-United States	14.94M	17.63M	13.48M	6.89M	7.97M
Ex-United States Growth	-15.26%	30.80%	95.69%	-13.60%	62.93%
Total	44.55M	57.56M	50.58M	47.68M	50.83M
Total Growth	-22.61%	13.80%	6.09%	-6.20%	10.87%

Source: S&P Global Market Intelligence.